共 169 条
[1]
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]
Ferlay J(2020)Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study Lancet Glob Health 8 e1027-e1037
[3]
Siegel RL(2021)The global breast cancer initiative: a strategic collaboration to strengthen health care for non-communicable diseases Lancet Oncol 22 578-581
[4]
Laversanne M(2009)Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer Clin Breast Cancer 9 Suppl 2 S73-81
[5]
Soerjomataram I(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-81
[6]
Jemal A(2022)Event-free survival with pembrolizumab in early triple-negative breast cancer N Engl J Med. 386 556-67
[7]
Heer E(2017)Adjuvant capecitabine for breast cancer after preoperative chemotherapy N Engl J Med 376 2147-59
[8]
Harper A(2021)Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer N Engl J Med 384 2394-405
[9]
Escandor N(2021)VP7–2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC Ann Oncol 32 1198-200
[10]
Sung H(2021)Tumor organoids: opportunities and challenges to guide precision medicine Cancer Cell 39 1190-1201